White Paper

Clear Guidelines for IND/CTA

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Clear Guidelines for IND/CTA

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful assessment of efficacy and toxicity prior to entering human trials. This document is intended to provide clear guidelines to help you plan your nonclinical assessment.

Altasciences' IND expertise and integrated processes can help you advance your drug development, faster. For a process overview and handy checklist, read more here:

Related resources from Altasciences

Show more

Supplier info centre